Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature

Francesc Cobo, G. de Celis, Arturo Pereira, X Latorre, Jaume Pujadas, Santiago Albiol

Anti-Cancer Drugs · 2007 · 41 citations · 11 references

Concepts

Abstract

We report a 59-year-old woman diagnosed with metastasic colorectal cancer who developed immune hemolytic anemia during FOLFOX chemotherapy (oxaliplatin/leucovorin/5-fluorouracil). Immunohematologic studies demonstrated that immune hemolysis was oxaliplatin-mediated. On the basis of this case and in a review of the literature in which 13 cases of previously reported oxaliplatin-induced immune cytopenia have been identified, we suggest some clinical clues regarding the use of oxaliplatin in cancer patients.

References

11